FDA grants CereVasc a breakthrough device designation for its investigational eShunt System and its use in treating communicating hydrocephalus.
FDA says its Electronic Submission Gateway Next Generation is live and ready to receive submissions.
Vanda Pharmaceuticals criticizes FDA for wrongly claiming that recent staff cuts and a new commissioner causes it to delay a company request for a hea...
Akeso says its ivonescimab met the primary endpoint in a pivotal Phase 3 trial for the first-line treatment of advanced squamous non-small cell lung c...
FDA warns ICU Medical that its Minneapolis, MN-based Smiths Medical ASD unit is illegally marketing adulterated and misbranded infusion pumps.
Federal Register notice: FDA seeks drug manufacturing establishments to participate in the second year of its voluntary Quality Management Maturity Pr...
FDA Matters founder Steven Grossman says FDA commissioner Martin Makary and the Trump administration are at a crossroads and need to decide whether th...
The International Council for Harmonization endorses and releases for comment its Q1 guidance on drug product stability testing.
